Diffusion Pharmaceuticals Inc (DFFN)

[abc1938]

$DFFN
everyone of you invested in Diffusion because you thought it could blow the roof as an added benefit to Remdesivir. We all want Romania's results to come back positive, and I'm sure it will. But you need to remember something that's worth a lot more than just being a COVID-19 therapeutic. Diffusion's TSC was developed to treat Acute Respiratory Disease Syndrome (ARDS). This first-in-class treatment was originally meant to deliver oxygen to vital organs in patients suffering from a stroke attack. Beyond this, the market is absolutely enormous. All pre-clinical trials have shown its safety and efficacy. When results get here, things will be outrageous. everyone needs to understand that.